INTEGRATED BIOPHARMA INC (INBP) › Operating IncomeINTEGRATED BIOPHARMA INC (INBP) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2011: -$362.0K2012: -$506.0K2013: $1.12M2014: $1.35M2015: $933.0K2016: $2.11M2017: $3.19M2018: $1.69M2019: $2.70M2020: $3.26M2021: $5.78M2022: $2.75M2023: $120.0K2024: $251.0K2025: $2.02M$2.02M2011Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$2.02M+704.8%2024$251.0K+109.2%2023$120.0K-95.6%2022$2.75M-52.5%2021$5.78M+77.5%2020$3.26M+20.5%2019$2.70M+59.6%2018$1.69M-46.8%2017$3.19M+50.8%2016$2.11M+126.6%2015$933.0K-31.0%2014$1.35M+21.1%2013$1.12M+320.6%2012-$506.0K-39.8%2011-$362.0K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share